DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 6, 2012, Pages 640-643

  Zhu, Xuan ^a   Zhong, Zhaohui ^a   Zhang, Xuanzhi ^a   Zhao, Xiaokun ^a   Xu, Ran ^a   Ren, Weigang ^a   Li, Songchao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

XRCC3 PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84862980736     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0334     Document Type: Article

References (25)

1. Andrew AS, Karagas MR, Nelson HH, et al. (2008) DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 65:105-118. (Pubitemid 350036684)
2. Bryan RT, Hussain SA, James ND, et al. (2005) Molecular pathways in bladder cancer: part 2. BJU Int 95:491-496. (Pubitemid 40311457)
3. Fontana L, Bosviel R, Delort L, et al. (2008) DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 28:1853-1856. (Pubitemid 351892896)
4. Gangwar R, Ahirwar D, Mandhani A, et al. (2009) Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Mutat Res 680:56-63.
5. Jemal A, Siegel R, Ward E, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96. (Pubitemid 351521864)
6. Kaufman DS, Shipley WU, Feldman AS (2009) Bladder cancer. Lancet 374:239-249.
7. Li F, Li C, Jiang Z, et al. (2011) XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology 77:511.e1-511.e5.
8. Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118:1590-1605. (Pubitemid 351632361)
9. Matullo G, Guarrera S, Carturan S, et al. (2001a) DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92:562-567. (Pubitemid 32319431)
10. Matullo G, Guarrera S, Sacerdote C, et al. (2005) Polymorphisms/ haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev 14:2569-2578. (Pubitemid 41752717)
11. Matullo G, Palli D, Peluso M, et al. (2001b) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22:1437-1445. (Pubitemid 32898701)
12. Mittal RD, Gangwar R, Mandal RK, et al. (2011) Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mol Biol Rep [Epub ahead of print]; DOI: 10.1007/s11033-11011-10906-z.
13. Narter KF, Ergen A, Agachan B, et al. (2009) Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 29:1389-1393.
14. Pierce AJ, Johnson RD, Thompson LH, et al. (1999) XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 13:2633-2638. (Pubitemid 29508550)
15. Probst-Hensch NM, Bell DA, Watson MA, et al. (2000) N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 9:619-623. (Pubitemid 30396186)
16. Rahim NG, Harismendy O, Topol EJ, et al. (2008) Genetic determinants of phenotypic diversity in humans. Genome Biol 9:215.
17. Sanyal S, Festa F, Sakano S, et al. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729-734. (Pubitemid 38618524)
18. Shen M, Hung RJ, Brennan P, et al. (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a casecontrol study in northern Italy. Cancer Epidemiol Biomarkers Prev 12:1234-1240. (Pubitemid 37499450)
19. Stern MC, Lin J, Figueroa JD, et al. (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 69:6857-6864.
20. Stern MC, Umbach DM, Lunn RM, et al. (2002) DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939-943. (Pubitemid 35014902)
21. Sun H, Qiao Y, Zhang X, et al. (2010) XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci 101:1777-1782.
22. Williams SG, Stein JP (2004) Molecular pathways in bladder cancer. Urol Res 32:373-385. (Pubitemid 40137329)
23. Zeegers MP, Tan FE, Dorant E, et al. (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630-639. (Pubitemid 30640110)
24. Zhang R, Chen W, Zhang W, et al. (2011a) Genetic polymorphisms of p53 codon 72 and bladder cancer susceptibility: a hospital-based case-control study. Genet Test Mol Biomarkers 15:337-341.
25. Zhang R, Xu G, Chen W, et al. (2011b) Genetic polymorphisms of glutathione S-transferase P1 and bladder cancer susceptibility in a Chinese population. Genet Test Mol Biomarkers 15:85-88.